Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis J Goodman

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Urologic Oncology|April 10, 2003
SELECT: the selenium and vitamin E cancer prevention trialEric A Klein, Ian M Thompson, Scott M Lippman, et al.
Cancer|March 2, 2005
Estimated impact of the Prostate Cancer Prevention Trial on population mortalityJoseph M Unger, Ian M Thompson, Michael LeBlanc, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 9, 2022
Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention TrialJeannette M Schenk, Cathee Till, Marian L Neuhouser, et al.
The Journal of Urology|August 12, 2005
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trialRuth D Etzioni, Nadia Howlader, Pamela A Shaw, et al.
Acta Ophthalmologica|July 24, 2020
Age-related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B)William G Christen, Amy K Darke, John M Gaziano, et al.
The Journal of Urology|April 18, 2007
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detectionIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 5, 2014
A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Erin E Martinez, Amy K Darke, Catherine M Tangen, et al.
International Journal of Cancer|January 1, 2009
Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, John F Alderete, Cathee Till, et al.
Journal of the National Cancer Institute|March 14, 2018
Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention TrialJoseph M Unger, Dawn L Hershman, Cathee Till, et al.
The Journal of Urology|April 14, 2012
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECTYair Lotan, Phyllis J Goodman, Ramy F Youssef, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Urologic Oncology|April 10, 2003
SELECT: the selenium and vitamin E cancer prevention trialEric A Klein, Ian M Thompson, Scott M Lippman, et al.
Cancer|March 2, 2005
Estimated impact of the Prostate Cancer Prevention Trial on population mortalityJoseph M Unger, Ian M Thompson, Michael LeBlanc, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 9, 2022
Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention TrialJeannette M Schenk, Cathee Till, Marian L Neuhouser, et al.
The Journal of Urology|August 12, 2005
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trialRuth D Etzioni, Nadia Howlader, Pamela A Shaw, et al.
Acta Ophthalmologica|July 24, 2020
Age-related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B)William G Christen, Amy K Darke, John M Gaziano, et al.
The Journal of Urology|April 18, 2007
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detectionIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 5, 2014
A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Erin E Martinez, Amy K Darke, Catherine M Tangen, et al.
International Journal of Cancer|January 1, 2009
Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, John F Alderete, Cathee Till, et al.
Journal of the National Cancer Institute|March 14, 2018
Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention TrialJoseph M Unger, Dawn L Hershman, Cathee Till, et al.
The Journal of Urology|April 14, 2012
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECTYair Lotan, Phyllis J Goodman, Ramy F Youssef, et al.
Pageof 16